MedPath

Intravenous Lipid Emulsion as an Adjuvant Therapy of Acute Clozapine Poisoning: A randomized Controlled Trial

Phase 2
Completed
Conditions
Injury, Occupational Diseases, Poisoning
Registration Number
PACTR201911916675189
Lead Sponsor
sara mohsen elsayed basiouny
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients (male or female) with moderate to severe acute clozapine poisoning according to poisoning severity score .

Exclusion Criteria

1.Asymptomatic and mild cases.
2.Pregnant and lactating women.
3.Patients with coingestion of other substances in addition to antipsychotics.
4.Patients with other major medical conditions (e.g. cardiovascular disease, renal or hepatic failure).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.